| Application no. and date | 07811048.3 (espacenet) (Federated) (European Patent Register), 20070802 | | Patent/reg. no. and date | DK/EP 2046331, 20101103 | | Publication date | 20090415 | | Priority no. and date | US 835752 P, 20060803 | | EP pub. no. and date |
EP 2046331 20090415 | | Effective date | | | Applicant/owner | CELGENE CORPORATION, 86 Morris Avenue
Summit, NJ 07901, US | | Applicant ref. no. | P81007612DK00E | | Inventor | ZELDIS, Jerome, B., 151 Library Place
Princeton, NJ 08540, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/454 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | Anvendelse af 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidin-2,6-dion til behandling af mantle cellelymfom | | Int. application no. | US2007017343 | | Int. publication no. | WO2008019065 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
